2024
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
2024
Jun 1, 2024, 12:41 |
Blog
Sumanta K. Pal: Loved this interview with Toni Choueiri in the The ASCO Post
Sumanta K. Pal shared a post on X: "Loved this interview with Toni Choueiri in the…
Jun 1, 2024, 12:35 |
Insight
Duaa Kanan: Check out our abstract on the role of CPS for PD-L1 expression in patients with NSCLC
Duaa Kanan, Internal Medicine Resident Physician at the University of Illinois College of Medicine Peoria,…
Jun 1, 2024, 12:25 |
Insight
Wafik S. El-Deiry: Our paper on preclinical dopamine effects on imipridones
Wafik S. El-Deiry shared on LinkedIn: "I am pleased to share our paper by Yiqun…
Jun 1, 2024, 12:22 |
Blog
Annabelle Gurwitch: Thanks ASCO for granting me a patient advocate scholarship
Annabelle Gurwitch shared a post by Charu Aggarwal, Leslye M. Heisler Associate Professor of Lung…
Jun 1, 2024, 12:12 |
Societies
Chris Boshoff: Pfizer announced a 5-year update from our Phase 3 study for patients with ALK+ advanced NSCLC
Chris Boshoff, Chief Oncology Officer and Executive Vice President at Pfizer, shared on LinkedIn: "Today…
Jun 1, 2024, 12:11 |
Societies
Carlos Torrado: Excited to present our poster at ASCO24
Carlos Torrado, Clinical Fellow at MD Anderson Cancer Center, recently shared a post by NCI…
Jun 1, 2024, 12:03 |
Insight
Myeloma Paper of the Day, June 1st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: MALT1 inhibition suppresses BCMA-induced NF-κB…
Jun 1, 2024, 11:55 |
Societies
Cristiane Bergerot: Exciting findings from ASCO24 by Nazli Dizman et al.
Cristiane Bergerot shared a post on X: "Exciting findings from ASCO24: CBM588, a Clostridium butyricum-based…
Jun 1, 2024, 11:50 |
Blog
Khalid El Bairi: I am officially an IDEA awardee!
Khalid El Bairi shared on X/Twitter: "Today marks one of my biggest achievements during my whole…
Jun 1, 2024, 11:46 |
Blog
Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "Phase 2 study (OptiTROP-Lung01) had promising results in patients with advanced…
1,114
1,115
1,116
1,117
1,118
All:
17910
Posts:
11151 - 11160
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube